Form 8-K - Current report:
SEC Accession No. 0001144204-14-039940
Filing Date
2014-06-27
Accepted
2014-06-27 06:01:13
Documents
2
Period of Report
2014-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v382555_8k.htm 8-K 33462
2 EXHIBIT 10.1 v382555_ex10-1.htm EX-10.1 70027
  Complete submission text file 0001144204-14-039940.txt   104986
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 14944040
SIC: 2834 Pharmaceutical Preparations